Purchase Order 75D30124P18603
- Not listed
- The Department of Health and Human Services Centers for Disease Control and Prevention awarded a $147,142.50 firm fixed price purchase order to Nanocellect Biomedical Inc., a for-profit biotechnology company, for the delivery of a WOLF System Cell Sorter on September 1, 2022. The contract has a completion date of September 30, 2022 and does not have a set-aside designation. Nanocellect Biomedical provides automated cell analysis, sorting, and dispensing equipment, services, and consumables to...
- This federal contract award is for the purchase of a WOLF system cell sorter from Nanocellect Biomedical Inc., a for-profit biotechnology company based in San Diego, California. The $99,765.00 fixed-price contract was awarded on May 17, 2019 by the Centers for Disease Control and Prevention (CDC) in Chamblee, Georgia. The award did not utilize a set-aside designation. Nanocellect Biomedical has provided cell sorting systems and related services to various federal agencies, including the NIH,...
- This firm fixed-price purchase order was awarded by the National Institutes of Health (NIH) Clinical Center to Nanocellect Biomedical Inc., a for-profit biotechnology company, for the delivery of a WOLF G2 cell sorter. The contract has a ceiling value of $145,575.00 and a period of performance through September 30, 2024. The award was made without the use of a set-aside designation. Nanocellect Biomedical has a history of providing cell sorting equipment and services to various federal agencies,...
- This is a firm fixed-price purchase order contract awarded by the National Institute of Mental Health (NIMH), a civilian agency within the National Institutes of Health (NIH), to Nanocellect Biomedical Inc., a for-profit biotechnology company. The $85,000.00 contract is for the delivery of Nanocellect's WOLF and WOLF G2 cell sorting systems and N1 single-cell dispensers, along with associated maintenance services. These advanced microfluidic cell analysis tools are designed to support a wide...
- The Environmental Protection Agency (EPA) Office of Research and Development awarded a $166,142.50 firm fixed-price purchase order to Nanocellect Biomedical Inc., a for-profit biotechnology company, for the delivery of a WOLF G2 cell sorter and N1 single-cell dispenser. This contract does not have a set-aside designation. Nanocellect Biomedical provides automated cell analysis, sorting, and dispensing equipment, services, and consumables to support biomedical research and development across...
- This is a $99,950 firm fixed-price purchase order awarded by the National Institute of Allergy and Infectious Diseases (NIAID), a civilian agency within the National Institutes of Health (NIH), to Nanocellect Biomedical Inc., a for-profit biotechnology company. The contract is for a WOLF cell sorter with accessories, which will support NIAID's research initiatives in areas such as malaria, vector-borne diseases, and single-cell genomic/transcriptional analysis. This sole-source award was made...
- The U.S. Environmental Protection Agency (EPA) awarded a $14,487.50 firm fixed-price purchase order to Nanocellect Biomedical Inc., a for-profit biotechnology company, for a service agreement to provide a WOLF G2 cell sorter and an N1 single-cell dispenser. The contract has an ultimate completion date of January 14, 2025. Nanocellect Biomedical is an experienced federal contractor, having provided similar cell analysis equipment and services to various agencies, including the National Institutes...
- Nanocellect Biomedical Inc., a for-profit biotechnology company, was awarded a $115,390.00 firm fixed price purchase order from the Department of Health and Human Services (HHS) National Institutes of Health (NIH) National Human Genome Research Institute. The award was for the provision of a NanoCellect WOLF Cell Sorter and N1 Cell Dispenser, which aligns with the original solicitation for these products. No set-aside designation was used. Nanocellect Biomedical has a history of providing...
- This is a firm fixed price purchase order contract awarded by the Department of Agriculture Agricultural Research Service to Nanocellect Biomedical Inc., a for-profit biotechnology company, for the provision of a NANOCELLECT WOLF CELL SORTER SYSTEM. The contract has a potential value of $117,940.00 and a completion date of August 24, 2018. The contract was not set aside for any specific business type. Nanocellect Biomedical Inc. provides automated cell analysis, sorting and dispensing equipment,...
- The Department of Health and Human Services National Institutes of Health (NIH) awarded a firm-fixed-price purchase order contract to Nanocellect Biomedical Inc., a for-profit organization, for a microfluidic cell sorter. The total potential value of the contract is $149,680.00, with a completion date of August 31, 2022. The contract does not have a set-aside designation. Nanocellect Biomedical is a biotechnology company that provides automated cell analysis, sorting, and dispensing equipment,...
This is a firm-fixed-price purchase order contract awarded by the Centers for Disease Control and Prevention (CDC) to Nanocellect Biomedical Inc., a for-profit biotechnology company located in San Diego, California. The contract has a ceiling value of $55,000.00 and a base year performance period running from April 27, 2024 to April 26, 2029. The contract is not designated as a set-aside award. Under this contract, Nanocellect Biomedical Inc. will provide the CDC with its WOLF G2 Cell Sorter and N1 Single Cell Dispenser, which are microfluidic-based cell sorting technologies used in biomedical research, drug development, and scientific investigation. Nanocellect Biomedical Inc. has a history of providing similar cell sorting equipment and services to various federal agencies, including the National Institutes of Health (NIH), Environmental Protection Agency (EPA), and Department of Veterans Affairs (VA). The company has also received a $2.6 million grant from the National Institute of General Medical Sciences (NIGMS) to develop an AI-aided tool for accelerating biopharmaceutical cell line development.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| P00001 | Exercise an Option | $10.6k | 4/25/25 | |
| Not listed | Not listed | $12.5k | 3/25/24 |